
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
Gagandeep Singh, Anass Abbad, Johnstone Tcheou, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 564-575
Open Access | Times Cited: 9
Gagandeep Singh, Anass Abbad, Johnstone Tcheou, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 564-575
Open Access | Times Cited: 9
Showing 9 citing articles:
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 587-599.e4
Open Access | Times Cited: 36
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 587-599.e4
Open Access | Times Cited: 36
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
Shoujie Huang, Xuefeng Zhang, Yingying Su, et al.
The Lancet (2024) Vol. 403, Iss. 10429, pp. 813-823
Closed Access | Times Cited: 27
Shoujie Huang, Xuefeng Zhang, Yingying Su, et al.
The Lancet (2024) Vol. 403, Iss. 10429, pp. 813-823
Closed Access | Times Cited: 27
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, et al.
mBio (2025)
Open Access
Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, et al.
mBio (2025)
Open Access
The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador
Aurora Malacatus-Arboleda, Erick Barbotó-Ramírez, Gonzalo E. Sánchez, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Aurora Malacatus-Arboleda, Erick Barbotó-Ramírez, Gonzalo E. Sánchez, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
Jan M. Sobczak, Irena Barkovska, Ina Baļķe, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 661-661
Open Access | Times Cited: 1
Jan M. Sobczak, Irena Barkovska, Ina Baļķe, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 661-661
Open Access | Times Cited: 1
The avidity of virus-specific antibodies obtained from <i>in vitro</i> stimulated memory b cells does not change one month after booster with Sputnik V or Comirnaty
Ekaterina A. Astakhova
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 3, pp. 465-470
Open Access
Ekaterina A. Astakhova
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 3, pp. 465-470
Open Access
An innate immune signature induced by AS01- or AS03-adjuvanted vaccines predicts the antibody response magnitude and quality consistently over time
Setareh Tasdighian, Viviane Bechtold, Ahmed Essaghir, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Setareh Tasdighian, Viviane Bechtold, Ahmed Essaghir, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine
Ekaterina A. Astakhova, Konstantin O. Baranov, Nadezhda Shilova, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1362-1362
Open Access
Ekaterina A. Astakhova, Konstantin O. Baranov, Nadezhda Shilova, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1362-1362
Open Access
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access